Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
CNS Oncology
|
November 4, 2014
Antiangiogenic therapies for glioblastoma
Isabel Arrillaga-Romany, Andrew D Norden
Planta Medica
|
March 8, 2003
Agrobacterium tumefaciens-mediated genetic transformation of the cardenolide-producing plant Digitalis minor L
Ester Sales, Juan Segura, Isabel Arrillaga
Plant Cell Reports
|
February 24, 2006
In vitro storage of cedar shoot cultures under minimal growth conditions
Begoña Renau-Morata, Isabel Arrillaga, Juan Segura
Tree Physiology
|
February 3, 2005
Factors influencing axillary shoot proliferation and adventitious budding in cedar
Begoña Renau-Morata, Javier Ollero, Isabel Arrillaga, et al.
Metabolic Engineering
|
June 3, 2008
Expression of spearmint limonene synthase in transgenic spike lavender results in an altered monoterpene composition in developing leaves
Jesús Muñoz-Bertomeu, Roc Ros, Isabel Arrillaga, et al.
Planta Medica
|
May 23, 2007
Enhancement of cardenolide and phytosterol levels by expression of an N-terminally truncated 3-hydroxy-3-methylglutaryl CoA reductase in Transgenic digitalis minor
Ester Sales, Jesús Muñoz-Bertomeu, Isabel Arrillaga, et al.
Plant Physiology
|
September 19, 2006
Up-regulation of 1-deoxy-D-xylulose-5-phosphate synthase enhances production of essential oils in transgenic spike lavender
Jesús Muñoz-Bertomeu, Isabel Arrillaga, Roc Ros, et al.
Expert Opinion on Investigational Drugs
|
December 11, 2013
Current status of antiangiogenic therapies for glioblastomas
Isabel Arrillaga-Romany, David A Reardon, Patrick Y Wen
Journal of Plant Physiology
|
August 25, 2014
Deoxyxylulose 5-phosphate reductoisomerase is not a rate-determining enzyme for essential oil production in spike lavender
Isabel Mendoza-Poudereux, Jesús Muñoz-Bertomeu, Isabel Arrillaga, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 10, 2026
Approved Targeted Treatments for Pediatric Brain Tumors
Eric Bouffet, David Neal Franz, Isabel Arrillaga-Romany, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
CNS Oncology
|
November 4, 2014
Antiangiogenic therapies for glioblastoma
Isabel Arrillaga-Romany, Andrew D Norden
Planta Medica
|
March 8, 2003
Agrobacterium tumefaciens-mediated genetic transformation of the cardenolide-producing plant Digitalis minor L
Ester Sales, Juan Segura, Isabel Arrillaga
Plant Cell Reports
|
February 24, 2006
In vitro storage of cedar shoot cultures under minimal growth conditions
Begoña Renau-Morata, Isabel Arrillaga, Juan Segura
Tree Physiology
|
February 3, 2005
Factors influencing axillary shoot proliferation and adventitious budding in cedar
Begoña Renau-Morata, Javier Ollero, Isabel Arrillaga, et al.
Metabolic Engineering
|
June 3, 2008
Expression of spearmint limonene synthase in transgenic spike lavender results in an altered monoterpene composition in developing leaves
Jesús Muñoz-Bertomeu, Roc Ros, Isabel Arrillaga, et al.
Planta Medica
|
May 23, 2007
Enhancement of cardenolide and phytosterol levels by expression of an N-terminally truncated 3-hydroxy-3-methylglutaryl CoA reductase in Transgenic digitalis minor
Ester Sales, Jesús Muñoz-Bertomeu, Isabel Arrillaga, et al.
Plant Physiology
|
September 19, 2006
Up-regulation of 1-deoxy-D-xylulose-5-phosphate synthase enhances production of essential oils in transgenic spike lavender
Jesús Muñoz-Bertomeu, Isabel Arrillaga, Roc Ros, et al.
Expert Opinion on Investigational Drugs
|
December 11, 2013
Current status of antiangiogenic therapies for glioblastomas
Isabel Arrillaga-Romany, David A Reardon, Patrick Y Wen
Journal of Plant Physiology
|
August 25, 2014
Deoxyxylulose 5-phosphate reductoisomerase is not a rate-determining enzyme for essential oil production in spike lavender
Isabel Mendoza-Poudereux, Jesús Muñoz-Bertomeu, Isabel Arrillaga, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 10, 2026
Approved Targeted Treatments for Pediatric Brain Tumors
Eric Bouffet, David Neal Franz, Isabel Arrillaga-Romany, et al.
Page
of 6